ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

TailorCare Impact Report Highlights Breakthrough Results in Musculoskeletal Care Outcomes

2024–2025 report shows 90% of TailorCare program patients improve in pain or function while their medical costs drop 40%

TailorCare, a leading provider of value-based specialty care solutions for musculoskeletal (MSK) health released its 2024–2025 Impact Report today, showing significant improvements in patient outcomes, cost savings, and scalable delivery of evidence-based care.

MSK conditions, such as arthritis, osteoporosis, and joint disorders, affect nearly 1 in 2 Americans and cost the U.S. more than $420 billion a year. TailorCare’s personalized, risk-bearing model helps patients navigate complex MSK conditions earlier and more effectively, avoiding unnecessary treatment, reducing costs, and improving quality of life.

Report highlights include:

  • Stronger Patient Engagement: Proprietary predictive model identified up to 87% of high-priority patients at risk of avoidable surgery six months in advance. In 2024, TailorCare completed ~12,000 clinical intakes and engaged nearly 1,000 patients each month.



  • Better Outcomes: 87% of members adhered to conservative care recommendations; 90% reported improvements in pain or function; and members rated TailorCare with a Net Promoter Score (NPS) of +90.



  • Lower Costs: Medicare Advantage (MA) members adhering to physical therapy saw a 40% reduction in medical costs. For MA members who had surgery, their out-of-pocket expenses were 14% lower.



  • Scalable Model: TailorCare now serves more than two million Medicare Advantage and commercial members across 50 states and is expanding its MA footprint in 2026 to cover hundreds of thousands of lives under full-risk contracts.

“At TailorCare, we’ve proven that better outcomes and lower costs aren’t mutually exclusive,” said Rachel Winokur, founder and CEO of TailorCare. “By earning trust, engaging patients early, and aligning with payer and provider incentives, we are reshaping MSK care nationally.”

The full 2024–2025 Impact Report is available at www.TailorCare.com/Impact-Report.

About TailorCare

TailorCare is a leading provider of specialty value-based care solutions focused on improving patient outcomes for joint, back, and muscle conditions. We take a deeply personal, data-driven approach by carefully assessing patients’ symptoms, health history, preferences, and goals for musculoskeletal health improvement. Utilizing predictive data and the latest evidence-based guidelines, we guide patients in choosing and navigating the most effective treatment pathways every step of the way. Learn more at www.tailorcare.com and follow us on LinkedIn at @TailorCare.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.56
+0.02 (0.01%)
AAPL  274.61
+0.50 (0.18%)
AMD  209.17
+1.59 (0.77%)
BAC  54.81
-0.52 (-0.94%)
GOOG  307.73
-1.59 (-0.51%)
META  657.15
+9.64 (1.49%)
MSFT  476.39
+1.57 (0.33%)
NVDA  177.72
+1.43 (0.81%)
ORCL  188.65
+3.73 (2.02%)
TSLA  489.88
+14.57 (3.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.